Cellectis S.A. CLLS
1.47
0.04
2.80%
as of 25 Sep
- Market cap
- $103.4M
- P/E
- 0.0×
Follow CLLS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (94.54%) | (76.34%) | (65.33%) | (30.75%) |
+8 more TTM periods Free account |
|
| (21.02%) | (20.58%) | (19.09%) | (9.57%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(77.52%) | (62.57%) | (52.28%) | (31.06%) | |
Average Days of Receivables |
72.06 | 61.93 | 101.80 | 108.18 | |
Free Cash Flow per Share |
(0.44) | (0.40) | (0.44) | (0.34) | |
Free Cash Flow |
(43.80) | (39.88) | (44.16) | (33.90) | |
Capital Expenditures |
(2.18) | (2.23) | (4.76) | (4.82) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(14.78%) | (11.69%) | (10.68%) | (7.77%) | |
Accounts Receivable Turnover |
3.38 | 4.20 | 3.67 | 3.22 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | (0.01) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
157.73% | 131.50% | 117.50% | 108.96% | |
Selling, General and Administrative Expense of Revenue |
33.44% | 27.53% | 24.86% | 24.13% | |
Share Based Compensation of Revenue |
12.23% | 9.05% | 7.68% | 5.75% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.56 | 0.58 | 0.82 | |
Depreciation/Fixed assets |
0.55 | 0.53 | 0.52 | 0.50 | |
Capex/Depreciation |
(0.11) | (0.11) | (0.24) | (0.23) | |
Revenue per Share |
0.63 | 0.75 | 0.79 | 0.82 | |
Operating CF per Share |
(0.41) | (0.37) | (0.39) | (0.29) | |
Capex per Share |
(0.02) | (0.02) | (0.05) | (0.05) | |
Capex to Sales |
0.03 | 0.03 | 0.06 | 0.06 | |
Net Profit Margin |
(102.34%) | (89.51%) | (84.92%) | (42.83%) |
Columns are period end dates